Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 21.63B 3.23B 2.9B 2.71B 2.46B 4.61B 307B 4.64B 32.52B 12.7B 159B 12.12B 11.86B 513B P/E 2026 *
14.6x
P/E 2027 * 12.7x
Enterprise Value 18.29B 2.73B 2.45B 2.29B 2.08B 3.9B 260B 3.92B 27.49B 10.74B 135B 10.25B 10.03B 434B EV / Sales 2026 *
0.62x
EV / Sales 2027 * 0.55x
Free-Float
34.77%
Yield 2026 *
4.96%
Yield 2027 * 5.49%
1 day-1.32%
1 week+2.97%
Current month+2.97%
1 month+2.68%
3 months-4.78%
6 months+9.85%
Current year+6.36%
1 week 18.2
Extreme 18.2
19.48
1 month 17.32
Extreme 17.32
19.48
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
27.1
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.002785
61.63
Manager TitleAgeSince
Chief Executive Officer 44 28/02/2019
Director of Finance/CFO 44 10/05/2018
Human Resources Officer 48 -
Director TitleAgeSince
Chairman 59 16/07/2013
Director/Board Member 63 08/08/2016
Chairman 48 28/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-1.32%+2.97%+11.48%-22.79% 3.23B
+1.62%+6.79%-39.03%-1.85% 15.09B
+14.93%+1.34%+9.86%-22.69% 7.24B
+2.45%+3.90%-13.52%-1.46% 6.12B
+3.35%+4.32%-12.26%+4.67% 6.01B
+2.96%+4.96%-50.25%-39.96% 5.92B
+1.85%+11.11%+7.42%-7.31% 4.6B
+0.67%+13.05%-34.43%-7.24% 3.33B
+3.34%+1.80%-23.18%-6.79% 3.11B
+0.75%-4.02%-28.01%-38.30% 3B
Average +3.07%+1.99%-17.19%-14.37% 5.77B
Weighted average by Cap. +3.55%+2.41%-20.31%-11.74%

Financials

2026 *2027 *
Net sales 29.54B 4.41B 3.97B 3.7B 3.35B 6.3B 420B 6.34B 44.41B 17.34B 218B 16.56B 16.2B 701B 32.52B 4.86B 4.37B 4.07B 3.69B 6.93B 462B 6.98B 48.9B 19.09B 240B 18.23B 17.84B 771B
Net income 1.49B 222M 199M 186M 169M 317M 21.11B 319M 2.23B 872M 10.96B 833M 815M 35.25B 1.71B 256M 230M 214M 194M 365M 24.32B 367M 2.57B 1B 12.62B 959M 939M 40.59B
Net Debt -3.34B -499M -448M -418M -379M -712M -47.46B -716M -5.02B -1.96B -24.63B -1.87B -1.83B -79.23B -3.76B -561M -505M -471M -427M -802M -53.43B -807M -5.65B -2.21B -27.73B -2.11B -2.06B -89.19B
Projected Income Statement - Annual - DaShenLin Pharmaceutical Group Co., Ltd.
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
15/10/26 CNY 18.74 -1.32% 13,992,110
14/10/26 CNY 18.99 +0.26% 14,142,196
13/10/26 CNY 18.94 -1.35% 14,478,966
12/10/26 CNY 19.20 +2.35% 16,594,205
09/10/26 CNY 18.76 +2.18% 13,582,012
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - DaShenLin Pharmaceutical Group Co., Ltd.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
18.99CNY
Average target price
23.75CNY
Spread / Average Target
+25.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - DaShenLin Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 603233 Stock